What We're Reading: ACA Plan Offerings Expand; Combo Pill Cuts CV Events; Biosimilar Savings
Health insurers are planning to expand their Affordable Care Act (ACA) plan offerings next year; a 4-in-1 pill can cut the risk of heart attacks and strokes; employers can see substantial savings with biosimilars if they implement a targeted effort to ecourage biosimilar use.
Insurers Will Expand ACA Plan Offerings
A handful of insurers are expanding their Affordable Care Act (ACA) plan offerings for next year, reflecting sharp rate increases that helped revenue catch up to claims costs, reported
Combo Pill Cuts Heart Attacks, Strokes
A daily pill that contains 4 different medicines and costs pennies a day can cut the risk of cardiovascular (CV) events, which researchers say can be particularly impactful in nations where there is limited access to doctors,
Employers Could See Significant Savings With Biosimilars
Employers could see substantial savings from biosimilars; however, these savings won’t come without a targeted effort to encourage biosimilar use, including through plan design, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025